Godrej Agrovet (GODREJAGRO) Q3 24/25 earnings summary

Executive summary

• Q3 FY25 revenue grew 4.5% year-over-year to ₹2,450 Cr, with EBITDA up 34% to ₹229 Cr and margin at 9.3%.

• Net profit for Q3 FY25 rose 34% year-over-year to Rs. 131.94 crore, driven by strong Animal Feed and Vegetable Oil performance.

• Strategic shift in poultry towards branded products improved profitability, while the dairy segment maintained steady revenue and margin performance.

• Board approved unaudited financial results for Q3 and nine months ended December 31, 2024, with unmodified auditor conclusions.

• Continued focus on ESG, CSR, and global sustainability commitments.

Financial highlights

• Q3 FY25 PAT rose 17% year-over-year to ₹99 Cr; PAT margin at 4.0%.

• Consolidated revenue for Q3 FY25 was Rs. 2,449.63 crore, up from Rs. 2,345.21 crore in Q3 FY24.

• Animal feed segment margins rose from 4% in Q3 FY24 to 6% in Q3 FY25; EBIT/ton increased 45% year-over-year to INR 1,935.

• Vegetable oil segment revenue grew 45% year-over-year, with segment margin at 23.7%.

• Astec LifeSciences reduced EBITDA loss to INR 4 crore in Q3 FY25 from INR 17 crore in Q3 FY24.

Outlook and guidance

• Animal feed EBIT/ton expected to exceed INR 2,100 in Q4; sustainable range for FY26 projected at INR 1,800–2,000.

• Dairy segment expects Q4 to outperform Q3, with higher value-added product sales and improved margins as price increases are implemented.

• Astec CDMO business to remain flat in FY25, with 30%+ growth targeted for FY26 based on confirmed orders.

• Enterprise business expects 14–16% volume growth in FY26, with a focus on cautious inventory management.